Reviva Pharmaceuticals Holdings Inc. - Warrants (25/12/2025)
RVPHW
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.4M
Close$
Compare to Similar Companies
| P/E Ratio | Dividends | Return on Equity | Price-to-Sales | Debt-to-Equity | ||
|---|---|---|---|---|---|---|
| Reviva Pharmaceuticals Holdings Inc. - Warrants (25/12/2025) | -0.2 | - | -113901094% | - | - | |
$0.39
12990% upside
Current Fair Value
12990% upsideUndervalued by 12990% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.40 Million |
|---|---|
| Enterprise Value | $-20,563,913.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.48 |
| Beta | -0.03 |
| Outstanding Shares | 7,022,945 |
Return
| Return on Equity | -113901093.61% |
|---|---|
| Return on Assets | -84317510.63% |
| Return on Invested Capital | -115822674.00% |
Valuation & Multiples
| P/E Ratio | -0.17 |
|---|---|
| PEG | 0.34 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 13, 2025
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Reviva Pharmaceuticals Holdings Inc.
5 employeesReviva Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing therapies that address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Reviva's primary ...